Efficacy and Safety of FTY720 for the Treatment of Acute Stroke

Trial Profile

Efficacy and Safety of FTY720 for the Treatment of Acute Stroke

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Fingolimod (Primary) ; Alteplase
  • Indications Stroke
  • Focus Proof of concept; Therapeutic Use
  • Most Recent Events

    • 22 Jul 2015 Status changed from recruiting to completed according to the results published in the Circulation according to the results published in the Circulation.
    • 22 Jul 2015 Primary endpoint (changes in hemorrhage volume) at day 1 has been met according to the results published in the Circulation.
    • 22 Jul 2015 Primary endpoint (changes in lesion volume from baseline (DWI) to day 1 (Flair)) has been met according to the results published in the Circulation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top